Short interest for Australian Oilseeds Hldgs gives investors a sense of the degree to which investors are betting on the decline of Australian Oilseeds Hldgs's stock. Short interest data is updated every two weeks.

Australian Oilseeds Hldgs Stock (NASDAQ:COOT), Short Interest Report

Australian Oilseeds Holdings Ltd through its subsidiaries, is focused on the manufacture and sale of chemical-free, non-GMO, sustainable edible oils and products derived from oilseeds. The company believes that transitioning from a fossil fuel economy to a renewable and chemical-free economy is the solution to many health problems the world is facing presently.

image-9

Long Ideas

News

Pre-Market Outlook

Markets

COOT

SHOT

Top 4 Defensive Stocks You&#39;ll Regret Missing This Quarter

Penny Stocks

Small Cap

Intraday Update

Movers

Trading Ideas

ABBV

AEHR

AKAN

BCAN

BCLI

CIFR

CYTO

CZOO

EGOX

ESPR

FLGC

FRGE

GDRX

IVVD

JWEL

LABP

LASE

LCID

LDOS

LICN

LICY

LPRO

MASI

MLGO

MSTR

NKTX

OCGN

OKYO

OTRK

SGMT

SINT

SLRX

SOND

STIM

SWVL

URGN

VMEO

XTLB

Shares of  Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Earnings

Eurozone

Commodities

Global

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 50 points on Monday.

Following the market opening Monday, the Dow traded down 0.16% to 39,412.36 while the NASDAQ fell 0.42% to 16,359.31. The S&amp;P 500 also fell, dropping, 0.23% to 5,222.33.

US Stocks Down; Chicago Fed National Activity Index Rises In February

Australian Oilseeds Holdings Limited - Ordinary Shares

Australian Oilseeds Holdings Ltd

Australian Oilseeds Holdings Limited - Warrant

CooTek (Cayman) Inc

Halozyme&nbsp;announced that Bristol Myers Squibb was reassigned a Prescription Drug User Fee Act goal date from the U.S. Food and Drug Administration for their Biologics License Application for the subcutaneous formulation of&nbsp;Opdivo&reg;&nbsp;(nivolumab) co-formulated with ENHANZE&reg;, Halozyme&#39;s proprietary recombinant human hyaluronidase enzyme, rHuPH20, across all previously approved adult, solid tumor&nbsp;Opdivo&nbsp;indications as monotherapy, monotherapy maintenance following completion of&nbsp;Opdivo&nbsp;plus&nbsp;Yervoy&nbsp;(ipilimumab) combination therapy, or in combination with chemotherapy or cabozantinib. The updated goal date is&nbsp;December 29, 2024.&nbsp;
The application is based on results from CheckMate-67T, the first Phase 3 trial of the subcutaneous formulation of nivolumab with ENHANZE&reg;&nbsp;to evaluate and demonstrate noninferior pharmacokinetics, efficacy and consistent safety vs. its intravenous formulation. If approved, subcutaneous nivolumab has the potential to be the first and only subcutaneously administered PD-1 inhibitor.&nbsp;

HALO

Halozyme Discloses That Bristol Myers Squibb Received Updated Action Date From U.S. FDA For Subcutaneous Nivolumab Co-Formulated with ENHANZE (Halozyme's Proprietary Recombinant Human Hyaluronidase Enzyme); The Updated Goal Date Is December 29, 2024

WIIM

GWAV

Greenwave Technology Solutions shares are trading lower after the company reported a year-over-year decrease in Q1 financial results. Also, the company announced a registered direct offering.

RELI

Reliance Global Group shares are trading lower after the company reported a year-over-year decrease in Q1 EPS results.

Reliance Global Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELI#NASDAQ">RELI</a>) reported quarterly losses of $(0.81) per share. This is a 37.29 percent decrease over losses of $(0.59) per share from the same period last year. The company reported $4.08 million in sales this quarter. This is a 3.63 percent increase over sales of $3.94 million the same period last year.

Reported Monday, Reliance Global Group Q1 EPS $(0.81) Down From $(0.59) YoY, Sales $4.08M Up From $3.94M YoY

Argus Research analyst David Toung upgrades Zimmer Biomet Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZBH#NYSE">ZBH</a>) from Hold to Buy and announces $150 price target.

Upgrades

Price Target

Analyst Ratings

Argus Research Upgrades Zimmer Biomet Holdings to Buy, Announces $150 Price Target

LAVA Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVTX#NASDAQ">LVTX</a>) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.12) by 83.33 percent. This is a 96.23 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $6.99 million which missed the analyst consensus estimate of $7.00 million by 0.11 percent. This is a 471.24 percent increase over sales of $1.22 million the same period last year.

Earnings Beats

Earnings Misses

LVTX

LAVA Therapeutics Q1 EPS $(0.02) Beats $(0.12) Estimate, Sales $6.99M Miss $7.00M Estimate

In a concurrent private placement, it is&nbsp;also selling to such investors unregistered warrants to purchase up to 420.596 million shares of common stock, which represents 100% of the number of shares of&nbsp;common stock being purchased in this offering.&nbsp;

Offerings

Reported Monday, Greenwave Technology Plans Offering To Certain Institutional And Accredited Investors 420.596M Shares Of Common Stock In Registered Direct Offering

The possibility of a spot Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) ETF getting approved has sent Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and ETH-related stocks, including Marathon Digital Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>), Riot Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) and Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), upwards in the pre-market.
What Happened: On Tuesday morning, crypto-related stocks opened positively during the pre-market session. Marathon Digital was trading 0.67% higher at $22.47 after closing at $22.32, while Coinbase was trading 3.69% higher at $233.50 after closing at $225.19. On the other hand, Riot, which closed at $10.96, was trading 1.82%% higher in the pre-market at $11.16, according to data from <a href="http://pro.benzinga.com">Benzinga Pro</a>
Why It Matters: This spike is attributed to the growing optimism surrounding the potential approval of spot exchange-traded funds in the U.S. Confidence in ETH comes as well-informed analysts<a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38926646/bitcoin-smashes-70k-ethereum-pumps-12-on-etf-approval-bombshell-odds-of-approval-75-tweets" target="_blank" rel="noreferrer noopener"> raised their odds of a spot ETH ETF approval</a> from 25% to 75%, resulting in the broader market rally. 
ETH&#8217;s large transaction volume more than tripled in the last 24 hours, indicating strong engagement from whales, <a href="https://app.intotheblock.com/?end_offset=20" target="_blank" rel="noreferrer noopener">according </a>to IntoTheBlock. Alongside, balances of long-term holders rose 0.38%, suggesting that the transactions were buyer-dominated.
On Monday, the SEC's Trading and Markets Division <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38929249/crypto-market-rallies-as-sec-reportedly-moves-forward-with-ether-etf-process" target="_blank" rel="noreferrer noopener">instructed asset managers to revise their 19b-4 filings</a> for the first U.S. ETFs holding Ethereum, leading to a surge in crypto prices.
Price Action: Ethereum is trading at $3,792.62, up 22.37% in the last 24 hours.
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

General

$BTC

$ETH

$WBTC

COIN

MARA

RIOT

Crypto-Related Stocks Are Trading Up To 4% Higher Premarket As Ethereum Gains 22% Amid Rising ETF Approval Odds

LUXH

LuxUrban Hotels shares are trading lower after the company announced the pricing of its public offering of 30.50 million common shares at $0.25 per share.

Nutanix will use Red Hat Enterprise Linux for traditional operating system capabilities in its offerings to accelerate innovation and fuel customer success across hybrid multicloud environments

NTNX

Nutanix Expands Collaboration With Red Hat To Power The Next-Generation Of Virtualized And Cloud-Native Workloads

Greenwave Tech Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWAV#NASDAQ">GWAV</a>) reported quarterly losses of $(0.39) per share. This is a 8.33 percent decrease over losses of $(0.36) per share from the same period last year. The company reported $8.51 million in sales this quarter. This is a 5.95 percent decrease over sales of $9.04 million the same period last year.

Reported Monday, Greenwave Tech Solns Q1 EPS $(0.39) Down From $(0.36) YoY, Sales $8.51M Down From $9.04M YoY

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a <a href="https://www.benzinga.com/yield-investments">high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer discretionary sector.
<h3 class="wp-block-heading">Marriott Vacations Worldwide Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VAC#NYSE">VAC</a>)</h3>
<ul>
<li>Dividend Yield: 3.10%</li>
<li>Stifel analyst Simon Yarmak maintained a Buy rating and raised the price target from $115 to $117 on May 7. This analyst has an accuracy rate of 65%.</li>
<li>Truist Securities analyst Patrick Scholes maintained a Buy rating and boosted the price target from $149 to $159 on March 5. This analyst has an accuracy rate of 72%.</li>
<li>Recent News: On May 6, Marriott Vacations posted better-than-expected quarterly earnings.</li>
</ul>
<h3 class="wp-block-heading">Tapestry, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>)</h3>
<ul>
<li>Dividend Yield: 3.30%</li>
<li>JP Morgan analyst Matthew Bossmaintained an Overweight rating and cut the price target from $56 to $54 on May 10. This analyst has an accuracy rate of 67%.</li>
<li>Baird analyst Mark Altschwagermaintained an Outperform rating and slashed the price target from $52 to $50 on May 10. This analyst has an accuracy rate of 67%.</li>
<li>Recent News: On May 9, Tapestry reported a third-quarter FY24 sales decline of 2% year-on-year to $1.482 billion, missing the analyst consensus estimate of $1.498 billion.</li>
</ul>
<h3 class="wp-block-heading">International Game Technology PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IGT#NYSE">IGT</a>)</h3>
<ul>
<li>Dividend Yield: 3.94%</li>
<li>Susquehanna analyst Joseph Stauff maintained a Positive rating and cut the price target from $40 to $33 on May 16. This analyst has an accuracy rate of 76%.</li>
<li>B. Riley Securities analyst David Bainreinstated a Buy rating with a price target of $30 on April 5. This analyst has an accuracy rate of 65%.</li>
<li>Recent News: On May 14, The company reported first-quarter adjusted earnings per share of 46 cents, beating the analyst consensus of 23 cents. Quarterly sales of $1.067 billion beat the street view of $1.029 billion..</li>
</ul>
Read More:  <a href="https://www.benzinga.com/news/24/05/38920102/jim-cramer-says-this-materials-stock-is-a-great-spec-plus-he-recommends-buying-abercrombie-fitch">Cramer Says This Materials Stock Is A &#8216;Great Spec,&#8217; Plus He Recommends Buying Abercrombie &amp; Fitch</a>

Dividends

These 3 Consumer Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts

The company announced that it intends to offer, subject to market conditions and other factors,&nbsp;$500,000,000&nbsp;aggregate principal amount of convertible senior notes due 2029 (the &quot;notes&quot;) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the &quot;Securities Act&quot;). BlackLine also intends to grant the initial purchaser of the notes a 13-day option to purchase up to an additional&nbsp;$75,000,000&nbsp;aggregate principal amount of the notes.
The notes will be senior unsecured obligations of BlackLine and will accrue interest payable semiannually in arrears. The notes will mature on June 1, 2029, unless earlier converted, repurchased or redeemed. The notes will be convertible into cash, shares of BlackLine&#39;s common stock (&quot;common stock&quot;) or a combination of cash and shares of BlackLine&#39;s common stock, at BlackLine&#39;s election. The interest rate, initial conversion rate and other terms of the notes will be determined at the time of pricing of the offering.

BlackLine Announces Proposed Private Offering Of $500M Of Convertible Senior Notes In A Private Placement To Qualified Institutional Buyers; Company Intends To Grant Initial Purchaser 13-day Option To Purchase Up To An Additional $75M

OneConnect Financial Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OCFT#NYSE">OCFT</a>) reported quarterly losses of $(0.21) per ADS. This is a 53.08 percent increase over losses of $(0.44) per ADS from the same period last year. The company reported $100.83 million in sales this quarter. This is a 25.50 percent decrease over sales of $135.33 million the same period last year.

OCFT

CORRECTION: OneConnect Financial Tech Q1 GAAP EPADS $(0.21) Up From $(0.44) YoY, Sales $100.83M Down From $135.33M YoY

Although U.S. stocks closed mixed on Monday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Global Partners</h3>
<ul>
<li>The Trade: Global Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLP#NYSE">GLP</a>) Global GP LLC <a href="https://www.benzinga.com/quote/HEAR/analyst-ratings">acquired a total of 30,000 shares</a>  an average price of $44.19. To acquire these shares, it cost around $1.33 million.</li>
<li>What's Happening: On May 8, Global Partners posted downbeat quarterly results.</li>
<li>What Global Partners Does: Global Partners LP is an U.S.-based limited partnership that acts as a midstream logistics and marketing company.</li>
</ul>
<h3 class="wp-block-heading">Vestis</h3>
<ul>
<li>The Trade: Vestis Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTS#NYSE">VSTS</a>) 10% owner Keith A. Meister acquired a total of 116,044 shares at an average price of $12.59. To acquire these shares, it cost around $1.46 million.</li>
<li>What's Happening: On May 7, Redburn Atlantic analyst Oliver Davies downgraded Vestis from Buy to Neutral.</li>
<li>What Vestis Does: Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada.</li>
</ul>
Don&#8217;t forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<h3 class="wp-block-heading">Citi Trends</h3>
<ul>
<li>The Trade: Citi Trends, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTRN#NASDAQ">CTRN</a>) 10% owner Pleasant Lake Partners LLC <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 41,450 shares</a> at an average price of $22.85. To acquire these shares, it cost around $946,940.</li>
<li>What's Happening: On March 19, Citi Trends reported worse-than-expected fourth-quarter financial results.</li>
<li>What Citi Trends Does: Citi Trends Inc is a retailer of urban fashion apparel and accessories in the United States.</li>
</ul>
<h3 class="wp-block-heading">HF Sinclair</h3>
<ul>
<li>The Trade: HF Sinclair Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DINO#NYSE">DINO</a>) Director Franklin Myers <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 6,500 shares</a> at an average price of $57.37. The insider spent around $372,905 to buy those shares.</li>
<li>What's Happening: On May 8, HF Sinclair reported mixed first-quarter financial results and announced a new $1 billion stock buyback.</li>
<li>What HF Sinclair Does: HF Sinclair is an integrated petroleum refiner that owns and operates seven refineries serving the Rockies, midcontinent, Southwest, and Pacific Northwest, with a total crude oil throughput capacity of 678,000 barrels per day.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/24/05/38920102/jim-cramer-says-this-materials-stock-is-a-great-spec-plus-he-recommends-buying-abercrombie-fitch">Jim Cramer Says This Materials Stock Is A &#8216;Great Spec,&#8217; Plus He Recommends Buying Abercrombie &amp; Fitch</a>

Insider Trades

CTRN

DINO

VSTS

$1.5M Bet On Vestis? Check Out These 4 Stocks Insiders Are Buying

Ready to cruise out of that dealership with a new set of wheels? Before you rev up your engines, make sure you're not driving off with a deal that'll sour faster than last week&#8217;s milk. Car shopping can be a wild ride, with pitfalls bigger than potholes. So, here are 7 tips that&#8217;ll help you steer clear of buyer's remorse and ensure you grab that dream ride without much regret.
<h3 class="wp-block-heading">1. Walk in With a Game Plan</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081248/car-dealership-visit-tips-1-1024x576.jpeg" alt="Don't just waltz into a dealership without a clue. That's a straight path to a financial facepalm. Image: Dall-E 3" class="wp-image-343353" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081248/car-dealership-visit-tips-1-1024x576.jpeg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081248/car-dealership-visit-tips-1-300x169.jpeg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081248/car-dealership-visit-tips-1-768x432.jpeg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081248/car-dealership-visit-tips-1.jpeg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Don&#8217;t just waltz into a dealership without a clue. That's a straight path to a financial facepalm. Image: Dall-E 3</figcaption></figure>
Wandering into a dealership without a plan is like heading to a buffet on an empty stomach: you might end up biting off more than you can chew. Know your car's value, understand what you can afford, and have a clear idea of your financial limits. This prep work is your best defense against a bad deal.
<h3 class="wp-block-heading">2. Stick to Your Guns</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081353/car-dealership-visit-tips-2-1024x576.jpeg" alt="Know that dealerships love to push cars they need to clear out. Image: Dall-E 3" class="wp-image-343355" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081353/car-dealership-visit-tips-2-1024x576.jpeg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081353/car-dealership-visit-tips-2-300x169.jpeg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081353/car-dealership-visit-tips-2-768x432.jpeg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081353/car-dealership-visit-tips-2.jpeg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Know that dealerships love to push cars they need to clear out. Image: Dall-E 3</figcaption></figure>
Dealerships love to steer you towards whatever they need to sell. If the car they're pushing isn't what you want, don't get sidetracked. Be firm about your choice because, at the end of the day, you're the one driving away in it.
<h3 class="wp-block-heading">3. Time Your Trade-In Chat</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081452/car-dealership-visit-tips-3-1024x576.jpeg" alt="Talking trade-in too early in the game can mess up your deal dynamics. Image: Dall-E 3" class="wp-image-343358" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081452/car-dealership-visit-tips-3-1024x576.jpeg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081452/car-dealership-visit-tips-3-300x169.jpeg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081452/car-dealership-visit-tips-3-768x432.jpeg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081452/car-dealership-visit-tips-3.jpeg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Talking trade-in too early in the game can mess up your deal dynamics. Image: Dall-E 3</figcaption></figure>
Hold off on talking trade-ins until you've nailed down the price of the new car. Jumping the gun can complicate negotiations, especially if you owe more on your current car than it's worth. Get the new car's price set in stone first, then talk trade.
<h3 class="wp-block-heading">4. Keep Your Keys and License</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081554/car-dealership-visit-tips-4-1024x576.jpeg" alt="Some old-school dealers might try holding onto your car keys or driver's license during a test drive to keep you in the dealership longer. Image: Dall-E 3" class="wp-image-343361" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081554/car-dealership-visit-tips-4-1024x576.jpeg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081554/car-dealership-visit-tips-4-300x169.jpeg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081554/car-dealership-visit-tips-4-768x432.jpeg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081554/car-dealership-visit-tips-4.jpeg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Some dealers try holding onto your car keys or license during a test drive to keep you in the dealership longer. Image: Dall-E 3</figcaption></figure>
Some dealers might ask for your keys or license during a test drive as a way to keep you in the showroom. Don't fall for it. You need your license with you, and your keys shouldn't be a bargaining chip.
<h3 class="wp-block-heading">5. Hold Off on Credit Checks</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081718/car-dealership-visit-tips-5-1024x576.jpeg" alt="Hold off on letting the dealership run a credit check until you're close to sealing the deal. Image: Dall-E 3" class="wp-image-343370" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081718/car-dealership-visit-tips-5-1024x576.jpeg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081718/car-dealership-visit-tips-5-300x169.jpeg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081718/car-dealership-visit-tips-5-768x432.jpeg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081718/car-dealership-visit-tips-5.jpeg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Hold off on letting the dealership run a credit check until you&#8217;re close to sealing the deal. Image: Dall-E 3</figcaption></figure>
Wait on that credit check until you're sure about the purchase. Each hard pull on your credit can ding your score, so save it for when you're close to sealing the deal.
<h3 class="wp-block-heading">6. Don't Just Focus on Monthly Payments</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081758/car-dealership-visit-tips-6-1024x576.jpeg" alt="Focus on the total cost of the car, not just the monthly payment. Image: Dall-E 3" class="wp-image-343371" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081758/car-dealership-visit-tips-6-1024x576.jpeg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081758/car-dealership-visit-tips-6-300x169.jpeg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081758/car-dealership-visit-tips-6-768x432.jpeg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081758/car-dealership-visit-tips-6.jpeg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Focus on the total cost of the car, not just the monthly payment. Image: Dall-E 3</figcaption></figure>
It's not just about fitting a car payment into your monthly budget. Focus on the total cost of the car. Long loan terms might reduce monthly payments, but they'll cost you more in the long run.
<h3 class="wp-block-heading">7. No Rush to Buy</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081906/car-dealership-visit-tips-7-1024x576.jpeg" alt="Just breathe and remember: the car market is hot, but deals aren't disappearing overnight. Image: Dall-E 3" class="wp-image-343380" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081906/car-dealership-visit-tips-7-1024x576.jpeg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081906/car-dealership-visit-tips-7-300x169.jpeg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081906/car-dealership-visit-tips-7-768x432.jpeg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/17081906/car-dealership-visit-tips-7.jpeg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Just breathe and remember: the car market is hot, but deals aren't disappearing overnight. Image: Dall-E 3</figcaption></figure>
Feel like you're being rushed to close the deal? Take a breath. The "today only" price pressure is a classic sales tactic. Remember, the market is brimming with options, and taking your time can lead to better deals.

Travel

5 Simple Tips To Avoid Falling For The Most Common Car Dealership Tricks

Purple Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPBT#NASDAQ">PPBT</a>) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.15) by 6.67 percent. This is a 44 percent increase over losses of $(0.25) per share from the same period last year.

PPBT

Purple Biotech Q1 2024 GAAP EPADS $(0.14) Beats $(0.15) Estimate, Cash $9.985M

AULT

Ault Alliance shares are trading higher after the company reported a year-over-year increase in Q1 financial results.

Argus Research analyst Bill Selesky upgrades Brinker International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAT#NYSE">EAT</a>) from Hold to Buy and announces $72 price target.

Argus Research Upgrades Brinker International to Buy, Announces $72 Price Target

Reflecting on the strategic plan launched in 2017 to acquire assets and grow the Company&#39;s topline across multiple sectors, Mr. Ault highlighted the long-term vision, &quot;It has been a bumpy road, but we remain steadfast in our mission to build on our core businesses and capitalize on emerging opportunities. By the end of 2027, assuming that we leased the Michigan data center and the power generated there were upgraded to 300 MW, we would expect revenues to exceed&nbsp;$500 million&nbsp;with gross margins in excess of&nbsp;50%. The Company expects the large majority of this growth to be driven by Sentinum and its data center operations.&quot;

Guidance

Ault Alliance Highlights Long-term Vision; Says It Remain Steadfast In Mission To Build On Its Core Businesses

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers that traders need to know about on Monday morning!



Moving stocks this morning are cannabis legalization, drug approval, a delisting update and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Next e GO (NASDAQ:<a href="https://investorplace.com/stock-quotes/egox-stock-quote/">EGOX</a>) stock is rocketing more than 127% alongside heavy pre-market trading this morning.</li>



<li>MicroAlgo (NASDAQ:<a href="https://investorplace.com/stock-quotes/mlgo-stock-quote/">MLGO</a>) shares are soaring close to 54% with strong early morning trading today.</li>



<li>Salarius Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/slrx-stock-quote/">SLRX</a>) stock is surging over 28% following the release of its <a href="https://www.nasdaq.com/press-release/salarius-pharmaceuticals-reports-fourth-quarter-and-full-year-2023-financial-results">latest earnings report</a>.</li>



<li>Canopy Growth (NASDAQ:<a href="https://investorplace.com/stock-quotes/cgc-stock-quote/">CGC</a>) shares are gaining 16% following <a href="https://www.nasdaq.com/press-release/canopy-growth-celebrates-passage-of-cannabis-legalization-in-germany-2024-03-22">cannabis legalization in Germany</a>.</li>



<li>Cazoo (NYSE:<a href="https://investorplace.com/stock-quotes/czoo-stock-quote/">CZOO</a>) stock is increasing more than 15% without any clear news this morning.</li>



<li>Flora Growth (NASDAQ:<a href="https://investorplace.com/stock-quotes/flgc-stock-quote/">FLGC</a>) shares are rising over 15% alongside cannabis legalization in Germany.</li>



<li>Esperion Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/espr-stock-quote/">ESPR</a>) stock is climbing more than 14% <a href="https://www.msn.com/en-us/money/markets/esperion-therapeutics-masimo-and-other-big-stocks-moving-higher-in-monday-s-pre-market-session/ar-BB1kuixT">following approval from the</a> Food and Drug Administration (FDA).</li>



<li>Forge Global (NYSE:<a href="https://investorplace.com/stock-quotes/frge-stock-quote/">FRGE</a>) shares are heading more than 14% higher ahead of its <a href="https://www.defenseworld.net/2024/03/24/forge-global-frge-to-release-earnings-on-tuesday.html">upcoming earnings report tomorrow</a>.</li>



<li>Nkarta (NASDAQ:<a href="https://investorplace.com/stock-quotes/nktx-stock-quote/">NKTX</a>) stock is jumping over 13% after <a href="https://www.nasdaq.com/press-release/nkarta-announces-pricing-of-%24240-million-underwritten-offering-2024-03-25">pricing an underwritten offering</a>.</li>



<li>Masimo (NASDAQ:<a href="https://investorplace.com/stock-quotes/masi-stock-quote/">MASI</a>) shares are up nearly 12% alongside <a href="https://www.nasdaq.com/press-release/politan-nominates-two-independent-candidates-for-masimo-board-2024-03-25">Board seat nominations</a>.</li>
</ol><h2>Top 10 Losers</h2><ol></ol><ol><li>MicroSectors FANG Index -3X Inverse Leveraged ETNs due January 8, 2038 (NYSEARCA:<a href="https://investorplace.com/stock-quotes/fngd-stock-quote/">FNGD</a>) stock appears to be crashing almost 90% but it&rsquo;s actually <a href="https://finance.yahoo.com/news/bmo-announces-reverse-split-three-211500378.html">undergoing a reverse stock split today</a>.</li>



<li>Trxade Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/meds-stock-quote/">MEDS</a>) shares are plummeting more than 35% on Monday morning.</li>



<li>Sintx Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/sint-stock-quote/">SINT</a>) stock is diving close to 34% after announcing a <a href="https://www.nasdaq.com/press-release/sintx-technologies-announces-proposed-public-offering-of-common-stock-2024-03-22">proposed public offering</a>.</li>



<li>Joann (NASDAQ:<a href="https://investorplace.com/stock-quotes/joan-stock-quote/">JOAN</a>) shares are decreasing over 16% as it <a href="https://www.streetinsider.com/8K/JOANN+Inc+%28JOAN%29+Stock+to+Be+Delisted+on+March+28th/22969264.html">prepares to be delisted</a>.</li>



<li>Murano Global Investments (NASDAQ:<a href="https://investorplace.com/stock-quotes/mrno-stock-quote/">MRNO</a>) stock is dropping nearly 15% <a href="https://investorplace.com/2024/03/why-is-murano-global-mrno-stock-up-over-130-today/">following a recent rally</a>.</li>



<li>Virios Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/viri-stock-quote/">VIRI</a>) shares are tumbling more than 12% after a Friday rally.</li>



<li>Movella (NASDAQ:<a href="https://investorplace.com/stock-quotes/mvla-stock-quote/">MVLA</a>) stock is taking an over 12% beating after <a href="https://www.nasdaq.com/press-release/movella-announces-appointment-of-marcum-llp-as-new-independent-registered-public">climbing on Friday</a>.</li>



<li>IMAC (NASDAQ:<a href="https://investorplace.com/stock-quotes/back-stock-quote/">BACK</a>) stock is falling more than 11% after a massive Friday rally.</li>



<li>Aurora Mobile (NASDAQ:<a href="https://investorplace.com/stock-quotes/jg-stock-quote/">JG</a>) shares are sliding more than 11% after announcing plans to <a href="https://www.nasdaq.com/press-release/aurora-mobiles-gptbots.ai-to-team-up-with-moonshot-ai-2024-03-25">team up with Moonshot AI</a>.</li>



<li>Australian Oilseeds (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COOT#NASDAQ">COOT</a>) stock closes out our pre-market stock movers down over 10% following its <a href="https://www.graincentral.com/news/australian-oilseeds-debuts-on-nasdaq/">public debut on Friday</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/03/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-march-25th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

CLEU, LWAY major consumer staples gainers; COOT, HPCO major losers

CGC, CYTO and IDN are among mid-day movers

Australian Oilseeds Holdings (COOT) has issued an update. In a significant move within the financial markets, EDOC completed a business combination...

Australian Oilseeds Holdings' Strategic Financial Overhaul

Yatsen Holding, 22nd Century among consumer staples movers

TAL Education and Mama's Creations among Consumer Staples movers

APEV, PACB and BILI are among premarket gainers

Lifeway Foods and SNDL among Consumer Staples movers

Andersons and Grand Canyon among Consumer Staples movers

AMBO

ANDE

APEI

ATNF

BACK

BCSA

BILI

BRFH

BRFS

BTTR

CLEU

DTCK

EDBL

FLYX

FNGD

FRPT

HKIT

HOLO

HPCO

INTZ

IPAR

JOAN

KAVL

KULR

LFVN

LINC

LOBO

LOPE

LWAY

MAIA

MAMA

MEDS

MNSO

MRNO

MVLA

NATR

NIVF

PACB

SMFL

SNAX

SNDL

STRA

VIRI

XPEV

XXII

ZVIA

Press Releases

Australian Oilseeds, Largest APAC Producer of Non-Chemical, Non-GMO "Cold-Processing" Vegetable Oil, Completes Transaction and Will Begin Trading on Nasdaq

Australian Oilseeds Announces Ringing of the NASDAQ Closing Bell to Celebrate Milestone

Australian Oilseeds, Largest APAC Producer of Non-Chemical, Non- GMO "Cold-Processing" Vegetable Oil, Expands Australian Operations to the United States

Australian Oilseeds, Largest APAC Producer of Non-Chemical, Non-GMO "Cold-Processing" Vegetable Oil, Enters into Contract with Woolworths and Costco Australia.

Australian Oilseeds Announces First Shipment of Sustainable Canola Oil to Neste

COOTW

Forafric Global

Branchout Food

								Get Alert
COOT	Australian Oilseeds Holdings L	05/09/2024	1.46%	6,090,790	88,844	75,254	1.18	Get Alert
COOT	Australian Oilseeds Holdings L	04/24/2024	0.76%	6,090,790	46,223	87,369	1	Get Alert
COOT	Australian Oilseeds Holdings L	04/09/2024	0.09%	6,090,790	5,653	136,088	1	Get Alert

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Australian Oilseeds Hldgs Stock (NASDAQ:COOT), Short Interest Report

People Also Watch